Eli Lilly has acquired Engage Biologics, a preclinical biotechnology company developing a novel DNA delivery system, for up to $202 million in cash. The pharmaceutical company's financing for the ...

The Royals recalled Morgan from Triple-A Omaha on Monday. Morgan will be up with the Royals for his third stint in the majors of the season. Over seven appearances for Kansas City, the righty reliever ...

It took 22 years, but Eli Manning has finally revealed the details behind one of the biggest draft controversies in NFL history. Back in 2004, the Chargers made Manning the No. 1 overall pick in the ...

The phrase "boat trip" will elicit strong emotional responses from certain New York Giants fans for as long as they remember the events of January 2017. Then-Giants quarterback and franchise legend ...

BMO Capital Markets Managing Director, BioPharma Equity Research Evan Seigerman joins Julie Hyman on Market Catalyst to discuss the battle for GLP-1 dominance between Novo Nordisk (NVO) and Eli Lilly ...

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks pulled back from ...

Eli Lilly's revenue surged 56% year over year to $19.8 billion in the first quarter. The healthcare giant has been working with regulators to lower prices for several of its products. But these ...

Eli Lilly LLY-1.93%decrease; red down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...